Healthcare Facility Onsite Testing

 No monthly contracts! Can order services for multiple shifts. Book as early as 7 days in advance.

PRICING MODEL

NURSE STAFFING

CORONAVIRUS TESTING

COMPREHENSIVE PLAN

Schedule with us today!

It's easy, fast and secure.

Caring for those who care for you!

CNS can provide nurses to staff your drive-thru coronavirus testing facility, as well as nurse assistance with testing patients in your healthcare facility. A CNS nurse will travel to your job site and assist your employees in helping to test your patients.

 

If CNS will be assisting your facility in conducting testing with your own facility-supplied Coronavirus testing kits, then your company will have to provide the necessary equipment, testing kits, and supplies.

If CNS will be providing your patients with health screenings and/or our *Covid-19 "Coronavirus" IgG/IgM serology rapid testing kits, then CNS will provide all necessary equipment, testing kits, and supplies. *Full health screenings includes complete vital signs + body systems review.

 

NURSE STAFFING

  1. Drive-thru / Medical Clinical Site testing 

CORONAVIRUS TESTING OPTIONS

  1. Covid-19 IgG/IgM Rapid Test with immediate results + Health Screening

  2. Covid-19 IgG/IgM Rapid Test only with immediate results (for pre-screened patients only)

HEALTH SCREENINGS, includes:

Vital signs checks:

  1. Temperature

  2. Pulse ox

  3. Respirations

  4. Blood pressure

  5. Pulse rate

 

Review of various human body systems commonly suspected to be related to Covid-19 and specific for client symptoms. Ex.

  • Respiratory system check by assessing cough, breathing, and lung sounds.

  • Musculoskeletal system check for pain and muscle aches.

  • And, many more body systems, such as nervous system, endocrine system, cardiovascular system, lymphatic system, digestive system and urinary system. 

*Learn more about Covid-19 IgG/IgM serology rapid tests by clicking HERE. Testing with COVID-19 "Coronavirus" IgG/IgM Rapid tests should only be performed in conjunction with other laboratory approved testing and/or clinical observations for the presumptive identification of viral infections in patients who may be infected with 2019nCoV (detected in China in 2019).